Aerial Avery
Podiatrist · Ada, OKNPI 1194915538
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,027 of the $12,980 with a category attached, or 69.5%. 26 manufacturers reported payments, led by Stryker at 42.0% of the total. Among podiatrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $53.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Amgen$2K
- Linvatec Corporation$1K
- Treace Medical Concepts, Inc.$1K
- Tactile Systems Technology Inc$968
- Integra Lifesciences Corporation$431
- plus $2K from 20 others
What the payments were for
- Speaking & faculty fees$8607%
- Travel & lodging$3,09324%
- Food & beverage$9,02770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 77 | $5,455 |
| Amgen | 78 | $2,279 |
| Linvatec Corporation | 6 | $1,040 |
| Treace Medical Concepts, Inc. | 4 | $1,023 |
| Tactile Systems Technology Inc | 21 | $968 |
| Integra Lifesciences Corporation | 5 | $431 |
| Pylant Medical | 5 | $369 |
| Organogenesis Inc. | 5 | $214 |
| Bioventus LLC | 9 | $183 |
| Kerecis Limited | 3 | $135 |
| Acera Surgical, Inc. | 1 | $127 |
| Trilliant Surgical LLC. | 2 | $121 |
| Misonix Inc | 2 | $118 |
| AbbVie | 6 | $87 |
| Nabriva Therapeutics, PLC | 4 | $80 |
| Smith+Nephew | 3 | $78 |
| Johnson & Johnson | 2 | $67 |
| Bsn Medical Inc | 2 | $51 |
| Trice Medical, Inc. | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $17 |
| Averitas Pharma Inc. | 1 | $16 |
| P Bar Medical LLC | 1 | $16 |
| Paragon 28, Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$2,580
- PROstep$1,702
- LINVATEC EXTREMITIES$1,014
- Lapiplasty System$894
- FLEXITOUCH$494
- ACTITOUCH$494
- ENTRE$494
- INTEGRA$392
- CYTAL$350
- ALLOWRAP$292
- PROLAYER$279
- ANCHORAGE$268
- BIOskin$175
- INFINITY$171
- STAR$171
- ACTISHIELD CF$163
- ALLOFIBER$163
- FIXOS$163
- INFINITY ADAPTIS$163
- KNOTILUS ANCHOR, 3.5MM$160
How this compares
$12,980 in reported general payments places this provider in the 95th percentile of 54 podiatrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other podiatrist in Ada
- Bryan BlanckAda$1K
- David CavallaroOklahoma City$22K
- Ahmed BukshEdmond$17K
- Patricia BoehleOklahoma City$10K
- Kevin DuxMuskogee$8K
- Barinder BassiTahlequah$7K
- Greg RohdeNorman$7K
- Thomas WicksChickasha$6K
- Tera SantistevanSapulpa$5K
- James StoughEnid$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.